| Name | ML364 | 
|---|---|
| Synonyms | 2-[(4-methylphenyl)sulfonylamino]-N-(4-phenyl-1,3-thiazol-2-yl)-4-(trifluoromethyl)benzamide | 
| Description | ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2), and can be used for the research of breast cancer, extracted from patent WO 2016134026 A1, compound Figure 10G. | 
|---|---|
| Related Catalog | |
| Target | 
                                
                                 USP2[1]  | 
                        
| References | 
| Molecular Formula | C24H18F3N3O3S2 | 
|---|---|
| Molecular Weight | 517.541 | 
| Exact Mass | 517.074 | 
| Appearance | white solid | 
| Storage condition | -20℃ |